New hope for kids with leukemia: engineering transplants to fight disease without dangerous side effects
NCT ID NCT07366801
Summary
This study is testing a new method for stem cell transplants in children with high-risk or relapsed leukemia. The goal is to prevent Graft-Versus-Host Disease (GVHD), a serious complication where donor immune cells attack the patient's body. Researchers are engineering the transplant by removing some immune cells and adding special 'regulatory' cells, hoping to reduce GVHD while still allowing the transplant to fight the leukemia and infections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA, RELAPSED are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National medical research center of pediatric haematology, oncology and immulogy named after Dmytriy Rogachyov, Moscow, 117198
RECRUITINGMoscow, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.